Back

AAV-HBV mouse model replicates immune exhaustion patterns of chronic HBV patients at single-cell level

Conceicao-Neto, N.; Han, Q.; Yao, Z.; Pierson, W.; Wu, Q.; Dockx, K.; Aerts, L.; De Maeyer, D.; Van den Berge, K.; Li, C.; Kukolj, G.; Zhu, R.; Podlaha, O.; Najera, I.; Van Gulck, E.

2023-08-07 immunology
10.1101/2023.08.07.552328 bioRxiv
Show abstract

Background and AimsUnresolved hepatitis B virus (HBV) infection leads to a progressive state of immune exhaustion that impairs resolution of infection, leading to chronic infection (CHB). The immune-competent AAV-HBV mouse is a common HBV preclinical immune competent model, though a comprehensive characterization of the liver immune microenvironment and its translatability to human infection is still lacking. We investigated the intrahepatic immune profile of the AAV-HBV mouse model at a single-cell level and compared with data from CHB patients in immune tolerant (IT) and immune active (IA) clinical stages. MethodsImmune exhaustion was profiled through an iterative subclustering approach for cell-typing analyses of single-cell RNA-sequencing data in CHB donors and compared to the AAV-HBV mouse model 24-weeks post-transduction to assess its translatability. This was validated using an exhaustion flow cytometry panel at 40 weeks post-transduction. ResultsUsing single-cell RNA-sequencing, CD8 pre-exhausted T-cells with self-renewing capacity (TCF7+), and terminally exhausted CD8 T-cells (TCF7-) were detected in the AAV-HBV model. These terminally exhausted CD8 T-cells (expressing Pdcd1, Tox, Lag3, Tigit) were significantly enriched versus control mice and independently identified through flow cytometry. Importantly, comparison to CHB human data showed a similar exhausted CD8 T-cell population in IT and IA donors, but not in healthy individuals. ConclusionsLong term high titer AAV-HBV mouse liver transduction led to T-cell exhaustion, as evidenced by expression of classical immune checkpoint markers at mRNA and protein levels. In both IT and IA donors, a similar CD8 exhausted T-cell population was identified, with increased frequency observed in IA donors. These data support the use of the AAV-HBV mouse model to study T-cell exhaustion in HBV infection and the effect of immune-based therapeutic interventions. Lay SummaryThe AAV-HBV mouse model is used as a research tool to study hepatitis B infection. In this study we evaluated the translation value from mouse to human with regards to T-cell exhaustion. HighlightsO_LIAAV-HBV mice transduced with a high titer vector showed presence of CD8 exhausted T-cells after 24 weeks. C_LIO_LIHigh titer transduced mice, but not lower titer show increased expression of LAG-3, TOX, TIM-3 and TIGIT in CD8 T-cells. PD-1 was increased in CD8 T-cells, independent of HBV transduction titer. C_LIO_LIA similar exhausted CD8 T-cell population could be found in chronic HBV donors, but not in healthy individuals. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=75 SRC="FIGDIR/small/552328v1_ufig1.gif" ALT="Figure 1"> View larger version (14K): org.highwire.dtl.DTLVardef@17db34dorg.highwire.dtl.DTLVardef@186a0b1org.highwire.dtl.DTLVardef@19fd39borg.highwire.dtl.DTLVardef@1fd9f64_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Hepatology
18 papers in training set
Top 0.1%
17.7%
2
PLOS ONE
4510 papers in training set
Top 24%
7.3%
3
BMC Medicine
163 papers in training set
Top 0.5%
6.4%
4
Journal of Hepatology
18 papers in training set
Top 0.1%
3.6%
5
Biology Methods and Protocols
53 papers in training set
Top 0.4%
2.8%
6
Journal of Medical Virology
137 papers in training set
Top 1%
2.6%
7
PLOS Pathogens
721 papers in training set
Top 4%
2.6%
8
Wellcome Open Research
57 papers in training set
Top 0.6%
2.1%
9
Journal of Clinical Virology
62 papers in training set
Top 0.3%
1.9%
10
Frontiers in Immunology
586 papers in training set
Top 4%
1.7%
11
Cytotherapy
14 papers in training set
Top 0.2%
1.7%
50% of probability mass above
12
Vaccines
196 papers in training set
Top 1%
1.7%
13
Journal of Translational Medicine
46 papers in training set
Top 1%
1.5%
14
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.3%
15
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 4%
1.3%
16
Viruses
318 papers in training set
Top 3%
1.3%
17
Journal of General Virology
46 papers in training set
Top 0.5%
1.2%
18
Virologica Sinica
10 papers in training set
Top 0.2%
1.2%
19
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
20
Gut
36 papers in training set
Top 0.6%
1.2%
21
eLife
5422 papers in training set
Top 49%
1.2%
22
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.1%
23
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
1.0%
24
Computers in Biology and Medicine
120 papers in training set
Top 3%
1.0%
25
BMC Genomics
328 papers in training set
Top 4%
1.0%
26
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.9%
27
Journal of Infection
71 papers in training set
Top 2%
0.9%
28
eBioMedicine
130 papers in training set
Top 3%
0.9%
29
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
30
IJID Regions
10 papers in training set
Top 0.2%
0.8%